Open AccessCHANGES IN HEPATITIS C VIRUS RNA VIREMIA CONCENTRATIONS IN LONG-TERM RENAL TRANSPLANT PATIENTS AFTER INTRODUCTION OF MYCOPHENOLATE MOFETIL
Author(s) -
Lionel Rostaing,
Jacques Izopet,
Karine Sandres,
JeanMarc Cisterne,
J Puel,
Dominique Durand
Publication year - 2000
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200003150-00055
Subject(s) - viremia , medicine , immunosuppression , mycophenolate , azathioprine , hepatitis c virus , gastroenterology , flaviviridae , viral load , immunology , hepatitis c , hepacivirus , transplantation , virus , disease
Mycophenolate mofetil (MMF) is a potent immunosuppressive agent and might inhibit chronic rejection, at least in primates. The prevalence of chronic hepatitis C virus (HCV) infection is high in renal transplant (RT) patients. To date, it has not been demonstrated whether MMF has any effect upon HCV viremia.